Quavonlimab (Anti-CTLA-4 / CD152), 1mg*25

Quavonlimab (Anti-CTLA-4 / CD152), 1mg*25

Ralpancizumab (Anti-PCSK9), 1mg*5

Ralpancizumab (Anti-PCSK9), 1mg*5

Ralpancizumab (Anti-PCSK9), 1mg

3.700,90 RON
SKU
SKM_A3022_1mg

Ralpancizumab (Anti-PCSK9) is a monoclonal antibody targeting selective proprotein convertase subtilisin kexin 9 (PCSK9). It has the potential in hemorrhagic stroke, hypercholesterolemic, dyslipidemia treatment. MW 145.28 KD.

Mai multe informatii
Price 3.110,00 RON (preturile sunt fara TVA)
Description

Ralpancizumab (Anti-PCSK9) is a monoclonal antibody targeting selective proprotein convertase subtilisin kexin 9 (PCSK9). It has the potential in hemorrhagic stroke, hypercholesterolemic, dyslipidemia treatment. MW 145.28 KD.